- Home
- RCUS vs CRSR Comparison
RCUS vs CRSR Comparison
Compare RCUS & CRSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- CRSR
- Stock Information
- Founded
- RCUS 2015
- CRSR 1994
- Country
- RCUS United States
- CRSR United States
- Employees
- RCUS N/A
- CRSR N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- CRSR Computer Manufacturing
- Sector
- RCUS Health Care
- CRSR Technology
- Exchange
- RCUS Nasdaq
- CRSR Nasdaq
- Market Cap
- RCUS 906.4M
- CRSR 1.0B
- IPO Year
- RCUS 2018
- CRSR 2020
- Fundamental
- Price
- RCUS $9.60
- CRSR $9.61
- Analyst Decision
- RCUS Buy
- CRSR Buy
- Analyst Count
- RCUS 8
- CRSR 6
- Target Price
- RCUS $20.86
- CRSR $10.00
- AVG Volume (30 Days)
- RCUS 891.1K
- CRSR 445.1K
- Earning Date
- RCUS 08-07-2025
- CRSR 07-31-2025
- Dividend Yield
- RCUS N/A
- CRSR N/A
- EPS Growth
- RCUS N/A
- CRSR N/A
- EPS
- RCUS N/A
- CRSR N/A
- Revenue
- RCUS $141,000,000.00
- CRSR $1,348,872,000.00
- Revenue This Year
- RCUS N/A
- CRSR $14.40
- Revenue Next Year
- RCUS $28.73
- CRSR $9.76
- P/E Ratio
- RCUS N/A
- CRSR N/A
- Revenue Growth
- RCUS N/A
- CRSR N/A
- 52 Week Low
- RCUS $6.50
- CRSR $5.60
- 52 Week High
- RCUS $18.98
- CRSR $13.02
- Technical
- Relative Strength Index (RSI)
- RCUS 53.46
- CRSR 54.40
- Support Level
- RCUS $9.14
- CRSR $8.98
- Resistance Level
- RCUS $9.62
- CRSR $9.64
- Average True Range (ATR)
- RCUS 0.44
- CRSR 0.32
- MACD
- RCUS 0.04
- CRSR -0.05
- Stochastic Oscillator
- RCUS 62.85
- CRSR 57.61
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.